Brief: Neovacs H1 Net Loss Widens To 6.4 Million Euros
Nov 20 (Reuters) - Neovacs SA ALNEV.PA :
* H1 OPERATING LOSS EUR 1.8 MILLION VERSUS LOSS EUR 4.7
MILLION
YEAR AGO
* AMBITIONS CONFIRMED IN ALL AREAS OF DEVELOPMENT
* H1 NET LOSS EUR 6.4 MILLION VERSUS LOSS EUR 3.8 MILLION
YEAR AGO
* CASH CONSUMPTION BY OPERATIONS AND INVESTMENTS AT 1.1 MEUR
IN
THE FIRST HALF OF 2020
Source text for Eikon: ID:nACT66224
Further company coverage: ALNEV.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants